Original-Research: beaconsmind AG - from NuWays AG Classification of NuWays AG to beaconsmind AG Company Name: beaconsmind AG ISIN: CH0451123589 Reason for the research: Update Recommendation: Buy from: 28.02.2024 Target price: 15.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Philipp Sennewald Strong order intake to start the year; chg.

Original-Research: beaconsmind AG (von NuWays AG): Buy

Original-Research: beaconsmind AG - from NuWays AG

Classification of NuWays AG to beaconsmind AG

Company Name: beaconsmind AG
ISIN: CH0451123589

Reason for the research: Update
Recommendation: Buy
from: 28.02.2024
Target price: 15.00
Target price on sight of: 12 Monaten
Last rating change: 
Analyst: Philipp Sennewald

Strong order intake to start the year; chg.
 
Topic: beaconsmind announced three major contract extensions, two of which
in the CloudWiFi hotspot segment, proving the strength of the groups newly
aligned product portfolio. In detail:
 
The company extended its collaboration with nursing homes operator Vitanas,
where beaconsmind will implement comprehensive Wi-Fi coverage at 15
additional locations. The project is scheduled to be rolled out in Q2 '24
and has a total sales volume of c. CHF 1m. In addition, the company also
expanded its contract with retail company Müller. After beaconsmind
implemented its Wi-Fi solutions in over 770 stores in the DACH region and
Spain in recent year, the company was now commissioned to install FREDERIX
CloudWiFi also in the remaing c. 145 stores in CEE. The project rollout is
scheduled for the first half of 2024 and should generate total sales in the
lower single-digit CHFm range (eNuW). With this, beaconsmind is once again
proving the compelling up- and cross-selling potential of the product
portfolio as well as the value-added from the recent acquisitions. On top
of this, beaconsmind gained property manager Reos GmbH as a customer, as
the company will roll-out a self-developed VPN network across all ten
locations of Reos. The deal is announced to have a total volume of c. CHF
0.5m.
 
Impact of transaction to unfold in H2. beaconsmind is seen to report a
solid set of FY figures in May, which are seen to display the full effect
of the recent acquisitions. In detail, we expect sales to come in at CHF
6.9m (H2: CHF 4.3m) and an EBITDA of CHF -0.6m (H2: CHF -0.1m). In FY '24e
sales are seen to increase to CHF 12.5m, which is in line with managements
guidance of CHF 12.6m, while EBITDA looks set to turn positive at CHF 2m.
The main drivers for this should be (1) the full effect of the acquisitions
of KADSOFT and T2 (closed in H2 '23), (2) synergy effects from crossselling
across the beaconsomind Group enhancing organic growth, (3) the ongoing
internationalization as well as (3) the continuously growing share of SaaS
revenues (see p. 2) allowing for improved operating leverage.
 
Mind you, the company looks set to continue its Buy & Build strategy (5
acquisitions in past 18 months) going forward. For 2024e, we expect
acqusitions to the tune of EUR 4-5m sales to be in the pipeline. Here,
management is seen to be looking for margin accretive, bolt-on acqusitions.
As future M&A is not included in our model, this leaves a certain upside to
our estimates.
 
Reiterate BUY with a new PT of EUR 15.00 based on DCF.

You can download the research here:
http://www.more-ir.de/d/28999.pdf
For additional information visit our website
www.nuways-ag.com/research.

Contact for questions
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.
Kontakt für Rückfragen
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: [e-mail]
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------transmitted by EQS Group AG.-------------------


The issuer is solely responsible for the content of this research.
The result of this research does not constitute investment advice
or an invitation to conclude certain stock exchange transactions.